Graphical Abstract Highlights d The SMUG1-DNA glycosylase promotes maturation of the telomeric DNA component, hTERC d SMUG1 regulates the presence of base modifications in hTERC d SMUG1 promotes DKC1 binding and stability of hTERC d hTERC levels limit telomerase activity in human SMUG1knockout cells
INTRODUCTION
Telomerase is a specialized ribonucleoprotein (RNP) complex that extends telomeric repeats at the ends of chromosomes (de Lange, 2005; Morin, 1989) . The telomerase holoenzyme consists of three main subunits: the telomerase reverse transcriptase (hTERT), the telomerase RNA component (hTERC), and the dyskerin complex (DKC1, NHP2, NOP1, and GAR1) (Egan and Collins, 2012; Schmidt and Cech, 2015) . hTERC is a highly structured non-coding RNA that carries the complementary template of the telomeric repeat sequence and two H/ACA domains that bind to dyskerin (Egan and Collins, 2012) . The hTERC/dyskerin RNP complex and hTERT associate in both nucleoli and Cajal bodies (CBs) during S phase, suggesting that both these subnuclear structures are involved in the biogenesis and trafficking of the telomerase complex (Lee et al., 2014; MacNeil et al., 2016) . hTERC biogenesis is a multistep process. First, hTERC is transcribed by RNA polymerase II (Pol II) to a primary transcript that can extend several hundred nucleotides downstream of the hTERC gene body Tseng et al., 2015) . The H/ACA complex is co-transcriptionally assembled and may mediate hTERC transcriptional termination and, thus, determine the length of the 3 0 extension (MacNeil et al., 2016) . Subsequent end-processing steps, leading to the formation of the 451-nt-long mature hTERC, involve polyadenylation by the Trf4/5-Air1/2-(TRAMP) complex, or the PARN/PABPN1 machinery, and processing by the nuclear exosome-targeting (NEXT) complex Tseng et al., 2015) . The balance between maturation and exosomal degradation determines the level of mature hTERC (MacNeil et al., 2016; Zinder and Lima, 2017) . Other RNA degradation pathways might also be involved in the removal of hTERC intermediates (Schmidt and Cech, 2015; Zinder and Lima, 2017) , and the detailed molecular mechanisms of hTERC maturation are not fully understood.
We recently demonstrated that the single-strand-selective uracil (SMUG1)-DNA glycosylase interacts and co-localizes with the pseudouridine synthase DKC1 (Jobert et al., 2013) . DKC1 is involved in the biogenesis and maturation of several RNA classes, such as rRNA (Ge et al., 2010) . SMUG1 associates with the 47S rRNA precursor, which is a major substrate of DKC1, and loss of SMUG1 leads to rRNA processing defects and accumulation of 5-hydroxymethyluridine (hmU) in rRNA. Thus, in addition to its function in DNA base excision repair (BER), SMUG1 acts in rRNA quality control (Jobert et al., 2013) .
As DKC1 functions both to support telomerase biogenesis in nucleoli and CBs as a structural component of the telomerase holoenzyme (Mitchell et al., 1999; Venteicher et al., 2009; Lee et al., 2014) , we tested a possible role for SMUG1 in telomere maintenance. We show that SMUG1 is present in CBs and observed a significant decrease in telomere length in human SMUG1knockout (KO) cells due to insufficient levels of mature hTERC to support telomerase activity. hTERC accumulated base modifications between the CR4/CR5 domain and the H box, a region important for DKC1 binding. Consistently, DCK1 was bound less efficiently in SMUG1-KO cells, leading to hTERC degradation. We conclude that SMUG1 promotes hTERC stability by regulating the presence of modified bases to allow binding of DKC1.
RESULTS

SMUG1 Influences DKC1 Localization
We previously observed that overexpression of a SMUG1 mutant unable to interact with DKC1 (E29R/E33R) affected DKC1 localization in HeLa cells (Jobert et al., 2013) . To confirm that disruption of the SMUG1/DKC1 interaction surface perturbs proper localization of DKC1, we repeated these experiments in Smug1 À/À mouse embryonic fibroblasts (MEFs) (Alsøe et al., 2017) . To exclude any bias originating from possible small differences in cell-cycle distribution, we scored the ring-shaped structures formed by DKC1 (DKC1 circles) during S phase (Lee et al., 2014) . In Smug1 À/À MEFs we observed fewer DKC1 circles (white arrows) and the appearance of dense nucleolar bodies (yellow arrows) ( Figures 1A and 1B ). The number of DKC1 circles could not be fully restored in cells stably expressing neither wildtype SMUG1 nor a mutant that does not have DNA-glycosylase activity on RNA substrates (H241L) (Figures 1A, 1B , and S1A). Confirming our previous data, expression of the DKC1-binding mutant exacerbated the phenotype (Figures 1A and 1B ). SMUG1/DKC1 interaction affects the DKC1 distribution pattern in nucleoli, which has been suggested to be the site for the biogenesis of the telomerase holoenzyme (Lee et al., 2014) before transport to the CBs (MacNeil et al., 2016) . Interestingly, in situ proximity ligation assay (PLA) showed SMUG1-Coilin interaction in the nucleus and CBs (Figures 1C and S1B) . Taken together, SMUG1 influences DKC1 organization in the nucleoli, possibly suggesting a role of SMUG1 in telomerase biogenesis.
Smug1 À/À Mice Exhibit Telomere Maintenance Defects As DKC1 is essential for telomerase biogenesis and regulation of telomere length (Mitchell et al., 1999) , we asked whether SMUG1 functions in telomere maintenance. Telomere chromatin immunoprecipitation (TeloChIP) showed that SMUG1 associated with telomeric chromatin (Figure 2A ). SMUG1 could not be detected at telomeres by telomere-specific fluorescent in situ hybridization (FISH) ( Figure S1C ), suggesting that SMUG1 transiently associates with telomeric DNA, consistent with the BER function. In tissue harvested from 3-to 4-month-old Smug1 À/À mice, a significantly reduced average telomere length was found in the heart (62% reduction; p = 0.017) but not in the spleen and brain ( Figure 2B ). To assess whether accumulation of DNA base damage in the form of SMUG1 substrates occurred in telomeric DNA, we digested the genomic DNA with SMUG1 and APE1 prior to telomere length measurements by qPCR. The presence of damaged bases would be expected to reduce the amplification efficiency. In this assay, increased telomeric DNA damage was detected only in heart tissue ( Figure 2B ). The average telomere length was similar in Smug1 À/À and isogenic wild-type MEFs ( Figure 2C ), but telomere-specific FISH revealed high frequencies of fragile telomeres in primary (Figures 2D and 2E) and transformed Smug1 À/À MEFs ( Figure S1D ). Strand-specific telomere-FISH probes showed a doubling of fragile telomeres on the leading C-rich strand in primary MEFs (Figure 2E ), while the G-rich strand was largely unaffected ( Figure S1E ). Transformed MEFs had significantly more fragile telomeric signals in both strands ( Figure S1D ).
The fragile telomere phenotype was even more pronounced in Smug1 À/À primary bone marrow cells. Both strands showed an increase in fragile telomeres, but the increase was more pronounced on the C-rich strand where close to 4% of the telomeric signals showed fragility on the C-strand, compared to less than 1% in wild-type bone marrow cells ( Figure 2F ). To assess whether telomere fragility had functional relevance in vivo, we measured the colony-forming capacity of primary bone marrow explant cultures ( Figure 2G ). The colony-forming unit abilities of the erythrocyte (BFU-E) and granulocyte (CFU-G) lineages in Smug1 À/À bone marrow explant cultures were reduced by 43% and 41%, respectively, in mice born from heterozygous parents (F1). As expected, based on a telomere maintenance phenotype, the colony-forming ability was further reduced in mice born from parents generated through five generations of interbreeding of homozygous Smug1-knockout mice (F6). In the F6 generation, the proliferative potentials of the macrophage lineage (CFU-M) and BFU-E were reduced by 40% and 61%, respectively ( Figure 2G ). Thus, loss of SMUG1 expression in mice led to reduced average telomere length and accumulation of telomere DNA damage in certain tissues. In addition, there was an asymmetric fragile-telomere phenotype affecting, primarily, the C-rich strand and reduced proliferative potential of primary bone marrow cells.
Dramatic Telomere Attrition in SMUG1-KO Human Cells Is Independent of BER Function
As telomere-associated phenotypes might be masked by the long telomeres of mice, we procured a human cell line in which SMUG1 expression was abrogated by a two-nucleotide deletion that introduces a premature stop codon after Asn56 of SMUG1 ( Figure 3A ). As expected, SMUG1 transcription was unaffected ( Figure 3B ), but no SMUG1 protein could be detected using an antibody directed toward an N-terminal epitope ( Figure 3C ). Thus, the mutation generated a loss-of-function, or extremely hypomorphic, allele. TeloChIP analysis revealed 4-fold enrichment of telomeric DNA in HAP1 SMUG1 wild-type (WT) cells relative to SMUG1-KO cells ( Figure 3D) , showing that SMUG1 also associates with telomeres in human cells.
Telomeric-FISH signals were barely detectable in SMUG1-KO cells, in stark contrast to the bright signals observed in the parental cell line ( Figure 3E ). Scoring of fragile telomeres was therefore not possible, but the fraction of telomeric signal-free ends was increased by at least 2-fold in two independent SMUG-KO clones ( Figures 3E and S2A ). The dramatic telomere attrition was confirmed by telomere restriction fragment (TRF) analysis, which showed that SMUG1-KO telomeres were 2.6 kb long on average, compared to 16.6 kb in isogenic WT cells ( Figure 3F ). The weak signals detected in lanes loaded with genomic DNA isolated from SMUG1-KO cells, despite equal loading, were also consistent with a reduced fraction of telomeric DNA. To assess whether accumulation of DNA base damage in the form of SMUG1 substrates occurred in telomeric DNA, we added SMUG1 and APE1 to the restriction enzyme cocktail. Base damage present within the telomere restriction fragment would be expected to reduce fragment length. Indeed, the mean telomere length was further reduced in the SMUG1-KO cells ( Figure 3F ), whereas no change in telomere length was seen in WT cells. Thus, base damage was present in telomeres in the absence of SMUG1, reducing the average fragment length from 2.6 to 1.7 kb ( Figure 3F , right).
The dramatic telomere attrition also affected the telomeric association of shelterin proteins. Both TRF1 and TRF2, which bind double-stranded telomeric DNA, exhibited a diffuse staining pattern in SMUG1-KO cells, in addition to the characteristic punctate telomere-specific staining (Figures 3G and S2B) . The reduced binding of shelterin components was corroborated by (A) Localization of DKC1 in Smug1 +/+ , Smug1 À/À , and Smug1 À/À MEFs complemented with wild-type mouse SMUG1, or SMUG1 mutants that do not bind DNA (H241L) or DKC1 (E31R/E35R). Representative immunofluorescence (IF) images of BrdU (red) and DKC1 (green) staining are shown. DNA was labeled with 4 0 ,6-diamidino-2-phenylindole (DAPI; blue). White and yellow arrows indicate DKC1 circles and dense bodies, respectively (scale bars, 2 mm). (B) Boxplot showing the frequency of ring-shaped structures characteristic for DKC1 in S-phase cells, with whiskers representing the 10th and 90th percentiles; the dark line within the box represents the median. n = 100 cells, *p % 0.05, and ****p % 0.0001 (two-tailed Student's t test). (C) Proximity ligation assay (PLA) showing FLAG-tagged SMUG1-Coilin interaction (red) in Cajal bodies (arrows). CBs were stained with Coilin (green). Scale bars, 1 mm.
the reduced association of POT1 and TFR2 with SMUG1-KO telomeres, as measured by TeloChIP ( Figures 3H and 3I ). We did not observe co-localization of TRF1 and the telomeric C-strand probe with gH2AX, suggesting that although shorter, SMUG1-KO telomeres remained bound to and protected by shelterin ( Figures S2C and S2D ). In conclusion, the loss of SMUG1 results in telomere maintenance defects characterized by fragile telomeres and tissue-specific telomere erosion in mice as well as dramatic telomere attrition in human HAP1 cells. (B) Telomere length and damage quantified in Smug1 À/À mouse tissues (heart, spleen, and brain) by qPCR. Data are presented as fold change relative to wild-type mice. (C) Telomere length in Smug1 +/+ and Smug1 À/À MEF cells at early (0-10) and late (30- 
(legend on next page)
Low hTERC Levels Limit Telomerase Activity in SMUG1-KO Human Cells Prompted by the above telomeric phenotypes, we measured telomerase activity and found that SMUG1-KO cells displayed an 11-fold reduction of activity compared to the control cell line ( Figure 4A ). Although hTERT mRNA expression was somewhat higher in SMUG1-KO cells than in the control ( Figure 4B ), the amount of hTERT protein was unchanged ( Figure 4C ). In contrast, hTERC levels were 6-fold lower in SMUG1-KO cells than in WT cells as measured by qPCR ( Figure 4B ), northern blotting (Figure 4D) , or RNA sequencing (RNA-seq) ( Figures 4E, S3A , and S3B). Interestingly, the number of hTERC reads aligning downstream of the core pseudoknot domain was reduced ( Figure 4E ). Next, we tested whether hTERC levels were limiting for telomerase activity in SMUG1-KO cells by overexpressing hTERC or hTERT (Figures 4F and S3C) . Indeed, transient expression of hTERC doubled telomerase activity in SMUG1-KO cells, whereas overexpressing hTERT had no effect (Figures 4F and S3C) .
Similarly, hTERC levels and telomerase activity increased when SMUG1-WT expression was restored in two independent stable clones of SMUG1-KO cells ( Figures 4G and S3D ). Consistently, telomere length was also increased ( Figure 4H ). Overexpression of a SMUG1 mutant unable to bind nucleic acids (NABm) extended telomeres to some degree whereas overexpression of DKC1-binding mutant (DBm) mirrored SMUG1-KO cells ( Figures S4D-S4F ). In sum, this strongly suggests that telomere attrition in the absence of SMUG1 was caused by low telomerase activity, which was, in turn, a direct consequence of an hTERC-biogenesis defect in SMUG1-KO cells.
SMUG1 Is Required for Co-transcriptional Processing of hTERC
Since the telomerase RNA component was found to be the limiting factor for telomerase activity in SMUG1-KO cells, we next asked whether SMUG1 binds hTERC. In RNA-immunoprecipitation experiments (RNA-IP), we detected 20-fold enrichment of hTERC using an anti-SMUG1 antibody compared to the immunoglobulin G (IgG) control ( Figure 5A ). Similarly, SMUG1 pull-down assays using recombinant SMUG1 protein as bait confirmed that SMUG1 bound directly hTERC without any intermediate protein when the total RNA isolated from HAP1 cells was used as prey ( Figure S4A ). The presence of modified bases in hTERC was essential for the interaction, as shown by the inability of SMUG1 to pull-down in vitro transcribed hTERC (Figures 5B and S4B) . Mature hTERC levels are determined by the balance between processing and degradation ( Figure S4C ) (MacNeil et al., 2016) . To test whether SMUG1 affects the equilibrium between different hTERC products, we measured the levels of the 451-nt mature hTERC and the two processing intermediates: 3 0 -extended and poly(A)-hTERC ( Figure 5C ). In SMUG1-KO cells, the reduced level of mature hTERC was accompanied by a 2.5-fold increase in 3 0 -extended hTERC (Figures 5C and 5D ) and a 1.5-fold increase in polyadenylated intermediates ( Figure 5C ). Thus, the absence of SMUG1 disturbed the balance between mature hTERC and its processing intermediates.
To further characterize these processing intermediates, we performed 3 0 -rapid amplification of cDNA ends (RACE)-seq experiments, which showed that the majority of reads aligning to the hTERC gene terminated at the expected end, although there was a small increase in fragments aligning from positions 451 to 458 ( Figure 5E ). Long 3 0 -extended RNA polymerase II readthrough products were not observed, suggesting that transcriptional termination and 3 0 end processing are functional in SMUG1-KO cells. However, accumulation of 3 0 -extended hTERC with short tails (> 10 nt) was detected (Figures 5F and 5G) . No dramatic differences in the poly(A) distribution could be observed ( Figure 5F ), but SMUG1-KO cells exhibited a 1.6-times-higher fraction of long (> 3 nt) poly(A) tails than WT cells (Figures 5G and 5H) . Taken together, these data suggest that SMUG1-KO cells have mild hTERC processing defects but that the polyadenylation and main hTERC end-processing machinery are functional.
The low levels of hTERC in SMUG1-KO cells were not due to reduced transcription, as Pol II occupancy at two sites in the hTERC promoter (Aalbers et al., 2012; Zhao et al., 1998) and in the coding region was unchanged (Figures 5I, 5J, and S3F). Measurements of nascent hTERC kinetics also confirmed a similar transcription rate in HAP1 cells ( Figure 5K ). Moreover, ChIP experiments showed that SMUG1 was present together with Pol II at the hTERC promoter and gene body ( Figure 5I ). In contrast to Pol II, which was stabilized at the hTERC gene ( Figure 5I , top), SMUG1 dissociated from chromatin after treatment with actinomycin D (ActD), suggesting that SMUG1 associates with (E) PNA-FISH in metaphase spreads of HAP1 cells. Telomeres were hybridized with a telomere-specific probe (Telo, 5-Carboxytetramethylrhodamine [TAMRA]) and chromosomes were stained with DAPI. Quantification of signal-free ends is shown in the bottom left (circles represent G-strand; triangles represent C-strand). (F) Representative southern blot of telomere restriction fragment length (TRF) assay in HAP1 cells is shown. Genomic DNA was digested with RsaI and HinfI restriction enzymes alone (Control, C) or RsaI and HinfI followed by incubation with SMUG1 and APE1 enzymes (DNA damage, D). Quantification of absolute telomere length (kb) is shown (right). Ethidium bromide staining is shown as loading control (left). An overview of the modified protocol is shown at the top. (G) Representative IFs for TRF1 in HAP1 SMUG1-WT and SMUG1-KO cells (scale bars, 2 mm). (H) POT1 and TRF2 binding to telomeric DNA in HAP1 cells assessed by TeloChIP followed by qPCR detection. Enrichment of the telomere-specific sequences immunoprecipitated with the indicated antibodies are presented as percent of input DNA. IgG, negative control. the actively transcribing Pol II complex ( Figure 5I , bottom). Interestingly, stabilization of Pol II at the hTERC gene after ActD treatment was not seen in SMUG1-KO cells ( Figure 5I ), suggesting that SMUG1 promotes stability of the stalled Pol II complex. Click-iT experiments showed an increased initial decay rate of hTERC in SMUG1-KO cells at 4 h that appeared to stabilize after 24 h ( Figure 5L ). No differences in hTERC transcription could be detected ( Figures 5I and 5K) , indicating that post-transcriptional mechanisms are the main cause of the observed instability of hTERC in SMUG1-KO cells. Taken together, our data show that SMUG1 is required for co-transcriptional processing of hTERC and affects its decay. 
SMUG1 Is Required for hTERC Maturation
Binding of SMUG1 to hTERC in RNA isolated from cells but not to in vitro transcribed hTERC strongly suggested that binding requires the presence of modified bases ( Figure 5B ). Thus, we asked if SMUG1 is required to remove modified or damaged hTERC molecules. Since the hTERC levels in SMUG1-KO cells were too low to allow direct detection of RNA damage by liquid chromatography-tandem mass spectrometry (LC-MS/MS) (Jobert et al., 2013) , we established an assay that detected the presence of SMUG1 substrates in specific regions of the hTERC transcript. The assay was based on reduced amplification of transcripts that contained modified bases after incubation with SMUG1 ( Figure 6A , left). Interestingly, there was no reduction of amplification efficiency upon enzyme treatment using primers that recognized the 5 0 end of the hTERC transcript ( Figure 6A , right). However, when using primers that amplified a fragment between the hTERC CR4/CR5 domain and the H box, we observed reduced amplification of RNA isolated from SMUG1-KO cells. The drop in amplification efficiency corresponded to a 20-fold increase in SMUG1-induced fragmentation at the hTERC 3 0 region in RNA isolated from (legend continued on next page) SMUG1-KO cells compared to the WT (Figure 6A, right) . No effect of pretreatment with APE1 alone was detectable (data not shown), suggesting that one or more modified bases that are substrates for SMUG1 are present in hTERC in human cells.
RNA-IP showed that DKC1 associated less efficiently with hTERC in SMUG1-KO cells ( Figure 6B ). Taken together, this suggests that the modified base(s) interfered with DKC1 binding. Since DKC1 stabilizes hTERC (Shukla et al., 2016; Venteicher et al., 2009; Vulliamy et al., 2008) , this reduced association might contribute to the reduced hTERC stability in SMUG1-KO cells.
It is also possible that the hTERC species containing 3 0 -modified bases were degraded. Indeed, increased 3 0 -polyadenylation of hTERC was observed in SMUG1-KO cells ( Figure 5C ). If these species are degraded, inhibition of pathways involved in hTERC degradation should restore hTERC levels. As expected, small interfering RNA (siRNA)-mediated depletion of EXOSC10, the major RNA exosome, resulted in stabilization of hTERC in WT cells (Figures 6C, left; Figure S5 ). Although no difference in hTERC abundance could be detected in WT cells upon PARN depletion, the expected accumulation of polyadenylated hTERC was observed ( Figure 6C , right). Simultaneous inhibition of the EXOSC10 and PARN enzymes did not result in any synergistic effects ( Figure 6C ), as expected, since these enzymes act in the same pathway (Shukla et al., 2016) . Interestingly, stabilization of hTERC was not observed in SMUG1-KO cells upon EXOSC10 silencing ( Figure 6C ).
We confirmed that DKC1 affects hTERC processing and stability (Shukla et al., 2016), as reduced hTERC was observed upon the depletion of DKC1 ( Figure 6D, left) . Interestingly, depletion of DKC1 in SMUG1-KO cells reduced hTERC levels further ( Figure 6D ). Depletion of PARN, either alone or together with DKC1, did not stabilize hTERC levels, but depletion of DKC1 together with EXOSC10 introduced a small stabilizing effect in both cell lines. High accumulation of polyadenylated hTERC upon DKC1 inhibition (96 h) was observed in SMUG1-KO cells ( Figure 6D , right), consistent with the role of DKC1 in hTERC stabilization. No further accumulation of polyadenylated hTERC could be observed upon the silencing of EXOSC10 or PARN in DKC1-depleted cells ( Figure 6D , right). These results suggest that SMUG1 is required to funnel hTERC to the exosome machinery and that hTERC depletion occurs via an EXOSC10-independent pathway in SMUG1-KO cells.
In conclusion, SMUG1 is required for co-transcriptional processing of hTERC and functions in hTERC biogenesis by regulating the presence of base modifications that interfere with DKC1 binding. Consequently, loss of SMUG1 leads to an imbalance between mature hTERC and its processing intermediates, which are degraded in an EXOSC10-independent RNA degradation pathway (Figure 7) .
DISCUSSION
Here, we show that human SMUG1-DNA glycosylase is required for the maturation of hTERC through regulating the levels of modified bases in a region important for DKC1 binding. In the absence of SMUG1, hTERC molecules containing modified bases and processing intermediates accumulate, accompanied by reduced levels of mature hTERC. An insufficient hTERC level limits telomerase activity in SMUG1-KO cells, leading to severe telomere attrition.
SMUG1 is a multifunctional enzyme that acts both in BER (Nilsen et al., 2001) and in RNA processing (Jobert et al., 2013) .
To determine which activity is more important for telomere maintenance, we used a complementation strategy where we found that hTERC levels were limiting for telomerase activity in SMUG1-KO cells. Ectopic expression of SMUG1 restored hTERC levels and telomerase activity. As this was accompanied by increased telomere length, we conclude that the telomere maintenance defects are caused by loss of SMUG1. The SMUG1/DKC1 interaction appears essential for this function as a SMUG1 mutant that cannot bind DKC1 failed to restore telomere length. Some restoration of telomere length was seen after complementation with a SMUG1 nucleic acid binding mutant that, consequently, has low DNA-glycosylase activity on synthetic substrates in vitro (Matsubara et al., 2004) . Because the ability to associate with DKC1 was preserved in this mutant (Jobert et al., 2013) , the inability of the nucleic acid binding mutant to restore telomere length to the same extent as SMUG1 WT suggested that the DNA-glycosylase activity is also required.
A function for the DNA-glycosylase activity was further supported by the fact that binding of SMUG1 to hTERC appeared to require the presence of modified bases as we could only detect the association with hTERC isolated from cells and not in vitro transcribed hTERC that lacked modified bases. hTERC exhibited a greater number of modified bases in a region between the CR4/CR5 domain and the H box, where DKC1 binds. The nature of the modified base(s) in hTERC remains unknown as we were unable, despite some stabilization of hTERC after (D) 3 0 -RACE products separated by agarose gel electrophoresis. (E) Position-specific read profiles for 3 0 RACE libraries. The graphs show the read depth for reads aligning to the hTERC gene locus, normalized to the maximum read depth within each library. The vertical dashed line shows the canonical hTERC 3 0 end as described . The insert shows a zoom-in of the region immediately after the 3 0 end. depletion of EXOSC10 and DKC1 ( Figure 6D ), to isolate sufficiently high amounts of hTERC from SMUG1-KO cells to perform lesion detection by LC-MS/MS. However, as treatment with APE1 alone did not reduce the amplification efficiency, we concluded that the base damage or modified bases accumulate in hTERC in SMUG1-KO are substrates for SMUG1. The likely substrate would be hmU or deoxyU, which we previously showed were substrates for SMUG1 in RNA (Jobert et al., 2013) . Culturing cells in the presence of hmU did not, however, stimulate the association between SMUG1 and hTERC (Figure S3E) . Thus, the association did not depend on exogenously induced modified RNA bases. The fact that we preferentially detected SMUG1 substrates toward the 3 0 end of hTERC, as opposed to a uniform distribution, is more consistent with the presence of a base modification, rather than random damage. hmU has been identified in RNA (Jobert et al., 2013) . Since it cannot be introduced into RNA by direct oxidation of thymine, it is likely formed by deamination of 5-hydroxymethylcytosine derived from 5-methylcytosine . It is tempting to speculate, therefore, that SMUG1 might regulate the presence of modified cytosines at two other methylated sites in hTERC, C323 and C455, which are located in the CR4/CR5 and the H box, respectively, the regions that accumulate base damage in SMUG1-KO cells.
Interestingly, the phenotype we observed in SMUG1-KO cells is reminiscent of that seen after depletion of HuR; HuR facilitated methylation of hTERC at C106, thereby promoting DKC1 binding to hTERC and assembly to hTERT (Tang et al., 2018) . Our data present the possibility that SMUG1 might function as a dynamic regulator of DKC1 binding in response to base modifications in the CR4/CR5 domain, but further characterization of the specific bases requires the development of new mapping techniques. Whether dynamic modification of hTERC alters its secondary Our data support a model where SMUG1 acts cotranscriptionally in hTERC biogenesis in a step upstream of the PARN/PABPN1 machinery by regulating the presence of modified bases in a region between CR4/CR5 and the H box. SMUG1 is required for efficient DKC1 binding and exosome-mediated degradation of these modified hTERC molecules. In SMUG1-KO cells the equilibrium between the mature hTERC and its processing intermediates is shifted toward degradation, leading to limiting amounts of hTERC unable to sustain telomerase activity. Figure by Ellen Tenstad/Science Shaped. structure or otherwise interferes with DKC1 localization ( Figure 1A) will be the focus of future studies.
hTERC levels could not be rescued by knocking down components of the RNA decay machinery. This suggests that SMUG1 is required to recruit the exosome and that other, yet-to-be-identified, degradation pathways may act in SMUG1-KO cells. Interestingly, SMUG1 stabilized the stalled RNA polymerase complex at the hTERC gene. The exosome is recruited co-transcriptionally, and Pol II backtracking provides a free RNA 3 0 end for the core (Lemay et al., 2014) . Our data do not suggest that SMUG1 affects hTERC transcriptional termination because long readthrough molecules were not observed. The absence of large differences in the poly(A) distribution shows that the end-processing machinery is functional in SMUG1-KO cells. However, SMUG1-KO cells harbored higher levels of slightly elongated hTERC molecules, exhibiting base modification(s) toward their 3 0 region. Hence, it is possible that SMUG1 acts co-transcriptionally to target hTERC containing hmU modified bases that interfere with DKC1 binding to the exosome.
Although the function of SMUG1 in hTERC biogenesis was the dominating phenotype in human SMUG1-KO cells, we did observe telomeric base damage ( Figure 3F ), which could contribute to the reduced binding of TRF2 and POT1 observed in TeloChIP experiments ( Figure 3H ), as the two main SMUG1 substrates (uracil [Vallabhaneni et al., 2015] and hmU [Theruvathu et al., 2014] ) interfere with shelterin assembly in vitro. In addition, the short telomeres contain less available substrate for TRF1 and TRF2 binding, which might be the main reason for dys-localization of these proteins in SMUG1-KO cells (Figures 3G and S2B) .
As observed previously in Ogg1 À/À (Wang et al., 2010), Nthl1 À/À (Vallabhaneni et al., 2013), and Ung À/À (Vallabhaneni et al., 2015) mice, Smug1 À/À MEFs and mice show increased DNA damage in telomeres and multiple telomere defects (Figures 2 and S1D) . In Smug1 À/À mice, fragile telomeres and reduced proliferative capacity of bone marrow cells are seen in the presence of TERT, whereas in the other DNA-glycosylase-knockout mice, telomere maintenance defects become obvious first in the background of TERT deficiency (Vallabhaneni et al., 2015) . It is possible that the function of SMUG1 in Terc biogenesis contributes to the apparently stronger telomere phenotype in Smug1 À/À mice, but although SMUG1 binds Terc in MEFs ( Figure S1F ), Smug1 À/À MEFs did not show consistently reduced Terc levels ( Figure S1G) . Therefore, the telomere maintenance defects in MEFs appear to be mainly caused by the loss of SMUG1-dependent BER (Alsøe et al., 2017) . Measurements of telomere fragility (Figures 2D, 2E , and S1D) indicated impaired replication of the C-rich telomere strand, which would be expected to contain more uracil lesions. However, as no method is available to discriminate between uracil and hmU in specific genomic regions, we do not know which SMUG1 substrate gives rise to these phenotypes in MEFs. Faithful BER of U has been shown to be needed to protect telomeres from unsolicited activation of mismatch repair at U:G pairs generated by activation-induced deaminase, leading to resection of the Crich strand in Ung À/À B cells (Cortizas et al., 2016) . We could not detect expression of AID in the HAP1 cells, but we cannot exclude the possibility that AID activation at one stage during establishment of the SMUG1-KO cell line is a cause of the extremely short telomeres in this cell line. In any case, the hTERC biogenesis defect prevented restoration of the telomeres.
Taken together, our data support a role of SMUG1 in telomere maintenance both as a BER enzyme and through its RNA processing function, but the extent to which these activities affect telomere maintenance differs between species and cell types. In human cells, SMUG1 acts in hTERC biogenesis by regulating the presence of modified bases in hTERC and facilitating DKC1 binding.
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LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and request for reagents may be directed to and will be fulfilled by the Lead Contact, Hilde Nilsen (h.l.nilsen@ medisin.uio.no). Plasmids and human and mouse lines generated in this study are stored in the lab biobank and are available under request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS Animals
Wild-type and Smug1 À/À C57BL/6J (male, 3-and 12-months old) mice were used for all the experiments. All mice were used straight after housing them until the appropriate experimental age. Animal maintenance, mouse handling and experimental procedures were performed in accordance to institutional guidelines and procedures approved by the Animal Experimentation Administration in Norwegian Food Safety Authority (NFDA). The generation of Smug1 À/À C57BL/6J mouse model was described previously (Alsøe et al., 2017) .
Cell Lines
Primary and transformed wild-type and Smug1 À/À mouse embryonic fibroblasts (MEFs) were generated from the gene-targeted Smug1 À/À , Smug1 tm1Hln , C57BL/6J mouse model previously established in our lab (Alsøe et al., 2017) . Timed matings were set up between either wild-type or Smug1 À/À mice born from heterozygous parents in order to obtain wild-type and Smug1 À/À embryos. Primary mouse embryonic fibroblasts (MEFs) were generated from ED13.5 to ED14.5 mouse tissue of wild-type and Smug1 À/À embryos. Limbs were removed from embryos, the tissue was chopped into small pieces and cell suspension of all embryos deriving from one female was made using a pipette. Transformed wild-type and Smug1 À/À MEFs were obtained by spontaneous transformation of the primary cultures. MEFs were grown in Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12, GlutaMAX (Invitrogen) supplemented with 10% (vol/vol) fetal bovine serum (FBS, Lonza), 1x Penicillin-Streptomycin (Invitrogen) and 1x MEM non-essential amino acids (Invitrogen). Primary MEFs (Passage 1) and cells cultured for 22 continuous passages were used. The MEF genotypes were authenticated by PCR genotyping for Smug1 À/À and SNPs for confirming C57BL/6J strain. HAP1 cells were edited by CRISPR/Cas9 to contain a 2bp deletion in a coding exon of SMUG1. HAP1 SMUG1-WT and SMUG1-KO cells (Horizon) were maintained in culture as predominantly diploid cells in Iscove's modified Dulbecco's medium (IMDM, Life Technologies) containing 10% (vol/vol) FBS and 1x Penicillin/Streptomycin.
HeLa cells were purchased from ATCC and cultivated in Dulbecco's Modified Eagle Medium, GlutaMAX (Invitrogen) supplemented with 10% (vol/vol) fetal bovine serum (FBS, Lonza) and 1x Penicillin-Streptomycin (Invitrogen). HeLa cells were derived from female tissue while HAP1 cells were from a male cell line.
Smug1 À/À MEF and HAP1 SMUG1-KO cells were complemented with different SMUG1 constructs cloned into the pHH25 vector. Transfection agents were FuGENE 6 (Promega) for MEF cells and Lipofectamine 3000 (Invitrogen) for HAP1 cells. Subsequently, stable cell lines re-expressing SMUG1 were selected using 2 mg/ml puromycin for MEFs and 1 mg/ml for HAP1 cells.
All the cell lines were cultured at 37 C and 5% CO 2 .
METHOD DETAILS
Cell Line Treatments
HeLa cells transfected with Flag-tagged SMUG1 were synchronized at early S-phase by a double thymidine block (Banfalvi, 2017) . Briefly, 24 h after seeding, cells were treated with 2 mM thymidine (Sigma-Aldrich) in complete medium for 14 h, washed twice in PBS and released in complete medium for 9 h. Then, cells were subjected to a second thymidine block (2 mM) for 14 h, washed twice in PBS and released in complete medium before fixation in PFA 4% at different time points.
To synchronize cells in S-phase, MEFs were seeded onto coverslips in a 24-well dish at 40% confluency. After 12 h, cells were serum starved for 42 h in DMEM supplemented with 0.5% FBS. Subsequently, cells were washed with 1x PBS and incubated in regular DMEM for another 24 h to re-enter the cell cycle. After 24 h, cells were given 1 h pulse with 20 mM bromodeoxyuridine (BrdU, BD Biosciences).
To inhibit RNA polymerase II, cells were treated for 2 h with 5 mg/ml of Actinomycin D (Sigma-Aldrich). For IR treatment, HAP1 cells were seeded onto coverslips in a 24-well cell culture dish and irradiated with 2 Gy. The next day, immunofluorescence experiments were conducted.
DNA and siRNA Transfections
For overexpression and siRNA experiments, HAP1 cells were seeded onto 6-well plates or 10 cm dishes and transfected 24 h later. The constructs used for hTERT and hTERC overexpression were pCDNA-3xHA-hTERT and pBS-U3-hTR-500 (Addgene). For siRNA experiments, either a scrambled control siRNA or the target-specific siRNA was used. Lipofectamine 3000 and Lipofectamine RNAiMAX (Invitrogen) transfection reagents were used as per manufacturer's indications. The target-specific siRNAs for PARN and EXOSC10 were purchased from Dharmacon as siGENOME SMARTpools; scrambled control and DKC1 siRNAs were purchased from Ambion. Cells were harvested 24 h later and siRNA treated 48, 72 or 96 h after transfection.
Immunofluorescence
Cells were seeded onto coverslips, fixed either in 70% ice cold ethanol for 10 min or with 4% paraformaldehyde at RT for 15 min and permeabilized with PBS containing 0.1% Triton X-100 at 4 C for 15 min. Cells were washed with 1x PBS and blocked for 1 h in PBS-BT solution (1x PBS, 3% BSA, 0.1% Triton X-100 and 0.05% sodium azide). Prior to blocking, antigen retrieval was necessary for BrdU labeling. Cells were incubated for 10 min on ice with 1 N HCl, 0.5% Triton X and 20 min 2 N HCl, 0.5% Triton X-100. Neutralization was followed, with 0.1 M sodium borate buffer pH 8.5. Cells were washed twice for 5 min in 1x PBS and incubated overnight at 4 C with primary antibodies in blocking solution. Cells were washed twice for 5 min in 1x PBS and secondary antibodies were added for 1 h (1:1000 dilution in PBS-BT). Cells were washed three times 5 min with 1x PBS. Coverslips were air-dried for 10 min, protected from light, and mounted onto ethanol rinsed glass slides using Prolong Diamond Antifade mounting medium containing DAPI and left at room temperature overnight. Images were acquired using a Zeiss LSM780 confocal microscope with a 63x objective and analyzed using the Zeiss Zen Blue software.
Proximity Ligation Assay (PLA) Synchronized Flag-tagged SMUG1 cells fixed after 4 h of release were used for Figure 1C . After fixation with PFA 4% for 20 min at RT, cells were permeabilized for 5 min in PBS 0.25% (vol/vol) Triton X-100. Cells were incubated in blocking solution (FBS 10% in TBS 0.1% [vol/vol] Tween-20) for 1 h at RT. Incubation with primary antibodies (anti-Flag (Sigma-Aldrich) and RNAPII (Abcam) or anti-Coilin (Cell Signaling Technology) diluted 1:200 in blocking solution) was carried out ON at 4 C. After three washes in PLA Washing buffer A, PLA was performed following the manufacturer's protocol. Briefly, PLUS and MINUS PLA probes were diluted 1:5 in Duolinkâ Antibody diluent and added to the coverslips for 1 h at 37 C. Cells were washed twice in PLA Washing buffer A and the ligation step (ligase diluted 1:40 in Ligation buffer 1x) was carried out for 30 min at 37 C followed by amplification (Polymerase diluted 1:80 in Amplification buffer 1x) for 100 min at 37 C. Coverslips were washed twice in PLA Washing buffer B for 10 min each, in PLA Washing buffer A for 1 min and counterstained for Coilin/RNAPII, incubating the cells with Alexa Fluor 488 conjugated anti-rabbit (Life Technologies) for 2 h at RT. Cells were washed twice in PLA Washing buffer A for 2 min, rinsed with PLA Washing buffer B 0.01x and mounted with Prolong Diamond Antifade mounting medium. Technical control, represented by the omission of the anti-Flag antibody, resulted in loss of PLA signal.
Antibodies
Primary antibodies used for immunofluorescence were DKC1 (1:500 and 1:50, Bethyl laboratories), BrdU (1:100, Abcam), Coilin (1:500, Cell Signaling Technology), Flag (1:200, Sigma-Aldrich), RNAPII (1:200, Abcam), TRF1 (1:500) and gH2Ax (1:500, Millipore). Secondary antibodies for immunofluorescence were purchased from Life Technologies: Alexa Fluor 594 conjugated goat-anti-rat/ rabbit antibodies and Alexa Fluor 488 conjugated goat-anti-rabbit/mouse antibodies. Immunoblotting and ChIP/RIP experiments were carried out using the following antibodies: SMUG1 (1:2000 
Western Blot
Whole-cell lysates were prepared in RIPA buffer [10 mM Tris-HCl (pH 8.0), 140 mM NaCl, 1 mM EDTA (pH 8.0), 0.5 mM EGTA, 0.1% SDS (wt/vol), 0.1% sodium deoxycholate (wt/vol) and 1% Triton X-100 (vol/vol)] containing protease inhibitors (Sigma-Aldrich). Protein extracts were run on any kD Mini-PROTEAN TGX precast gel (Bio-Rad) and blotted on nitrocellulose or PVDF membranes. Blots were blocked in either 5% non-fat milk or 5% BSA dissolved in 1x PBS, 0.1% Tween-20 (blocking solution). After the incubation with the specific primary antibody, secondary antibody incubation was carried out for 1 h (1:3000 in blocking solution) at RT. Blots were developed with SuperSignal West Pico or Femto Chemiluminescent substrate (Thermo Scientific). The signals were detected with a LAS-3000 mini imaging system (FujiFilm) and quantified with Multi Gauge V3.1 software.
hTERC In Vitro Transcription cDNA from HAP1 SMUG1-WT cells was used as a template to amplify hTERC for the in vitro transcription reaction. The primers used were: T7_hTERC_F, 5 0 -CCAAGCTTCTAATACGACTCACTATAGGGAGAGGGTTGCGGAGGGTGGGCCT-3 0 and T7_hTERC_R, 5 0 -GCATGTGTGAGCCGAGTCCTGG-3 0 . PCR-amplified DNA was subsequently used as template to transcribe hTERC RNA in vitro by using the MEGAscript T7 transcription kit (Life Technologies), following the manufacturer's instructions.
Expression and Purification of SMUG1 E. coli BL21(DE3) cells harboring pETM-11-hSMUG1 WT or H239L mutants were grown in LB media with kanamycin (50 mg/ml) at 37 C until OD 600 reached 0.6. The protein expression was induced with IPTG at 37 C for 2 h (final concentration 0.25 mM). The following procedures were performed at 4 C. Cells pelleted from 1 l culture were resuspended in 15 mL buffer A [50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM b-mercaptoethanol], disrupted by sonication (4 3 30 s at 60% amplitude), centrifuged (15000 rpm, 30 min), and incubated with 3 mL Ni-NTA agarose (QIAGEN) for 1 h with light agitation before loading onto an Econo-column (Bio-Rad; 2.5 3 20 cm). The column was washed with buffer A (50 ml); the fusion protein was eluted with buffer A containing 50 mM Imidazole (3 3 5 ml) and buffer A containing 150 mM Imidazole (3 3 5 ml). For hSMUG1 H239L, the eluted fractions were pooled and concentrated, glycerol was added (final concentration 25%) and stored at À20 C. For hSMUG1 WT, the eluted fractions were dialyzed against buffer B [20 mM MES pH 6.5, 50 mM NaCl, 10 mM b-mercaptoethanol] overnight. The fraction was centrifuged to remove the precipitate and concentrated to 10 ml, and loaded onto a Bio-Scale Mini Macro-Prep High S cartridge (Bio-Rad, 5 ml) onto the BioLogic DuoFlow 10 System (Bio-Rad). The column was washed with Buffer B and eluted with a linear gradient of NaCl (50-2000 mM) in buffer B. The fractions containing hSMUG1 were pooled and concentrated, glycerol was added (final concentration 25%) and stored at À20 C. In order to remove potential aggregated or degraded protein before His-tag and SMUG1 pulldown assays, diluted protein (1:10 in buffer A containing 10 mM Imidazole) was loaded onto 200 mL of pre-equilibrated Ni-NTA resin into Ultrafree-MC device (Sigma-Aldrich, 0.5 ml) and incubated for 30 min with light agitation. The resin was washed twice with buffer A containing 20 mM Imidazole (500 ml) and the protein eluted in 200 mL buffer A containing 250 mM Imidazole.
His-tag and SMUG1 Pulldown
For the His-tag and SMUG1 pulldown experiments, 0.2 nmol of either full-length Hist-tag SMUG1 WT or SMUG1 H239L mutant was added, together with total RNA isolated from HAP1 SMUG1-WT cells (300 mg per reaction) or in vitro transcribed hTERC (5 mg per reaction) to 10 mL of HIS-Selectâ Nickel Magnetic Agarose beads (Sigma-Aldrich) or 20 mL Protein G magnetic beads (Life Technologies) conjugated with SMUG1 antibody (Abcam). As negative control, prior performing the assay, SMUG1 WT protein was heat inactivated at 65 C for 20 min. Binding was performed in PBS completed with protease inhibitor cocktail 1x (Sigma-Aldrich) for 3 h at 4 C under rotation. The beads were washed three times in washing buffer (PBS supplemented with 1% Igepal CA-630) and resuspended in Trizol (Invitrogen) or Laemmli sample buffer for RNA isolation and western blotting, respectively.
RNA Isolation and qPCR
Total RNA was isolated with either RNeasy kit (QIAGEN) or with Trizol (Invitrogen) following the manufacturer's instructions. Reverse transcription was performed using the cDNA synthesis kits (Bio-Rad). Quantitative PCR was carried out on a QuantStudio 7 Flex detection system (Applied Biosystems) with Power SYBR green PCR master mix (Applied Biosystems). Each sample was analyzed in triplicate.
EU Incorporation, Quantification of Nascent hTERC Kinetics, and hTERC Decay
Detection of nascent hTERC and its decay were analyzed by using the Click-iTâ Nascent RNA Capture kit (Life Technologies). 5-ethynyl Uridine (EU) (Life Technologies) was dissolved in DMSO at a concentration of 200 mM. HAP1 cells were incubated with 0.2 mM EU for different time points (1, 4, 8 and 24 h) for capturing the nascent hTERC or pulsed for two hours and chased for 4 and 24 h for analyzing the hTERC decay. Cell pellets were harvested and total RNA prepared using Trizol reagent (Invitrogen). The biotinylation, the streptavidin binding and cDNA synthesis were performed as per manufacturer's instructions. qPCR analysis was performed using the standard protocol.
RNA Sequencing and Analysis
RNA integrity was verified using the 2100 Bioanalyzer instrument. RNAs, spiked with control RNAs (Lexogen SIRV-Set 3) during cell lysis prior to RNA isolation, were submitted to the Genomic Core Facility (NTNU) for library preparation (Lexogen SENSE Total RNA-Seq Library Prep Kit) and sequencing (76 nucleotide paired end sequencing on an Illumina NextSeq 500 High Output flow cell). Sequence reads were aligned to the human genome (version GRCh38.p7) and to the control RNA sequences with the STAR aligner (Dobin et al., 2013) . Read counts per gene (Encode release 84) were determined with htseq-count (Anders et al., 2015) . The gene count matrix was normalized with voom (Law et al., 2014) , using normalization factors computed with the TMM method (Robinson and Oshlack, 2010) from the reads aligning to the control RNAs. The normalized matrix was analyzed for differential gene expression with limma (Ritchie et al., 2015) . Data is deposited in GEO: GSE116580.
hTERC RNA Damage Assay RNA isolated from HAP1 cells was digested with 2 U of SMUG1 (New England Biolabs) at 37 C for 30 min and then retro-transcribed with SuperScript IV RT (Invitrogen) following the manufacturer's instructions. Then, the cDNA was assayed via ddPCR using Droplet Digital PCR QX system (Bio-Rad). Briefly, the cDNA was added to a 20 mL PCR mixture containing 10 mL 2x QX200 ddPCR EvaGreen Supermix (Bio-Rad) and 100 nM hTERC specific primers. 20 mL of PCR mixture and 70 mL Droplet generation oil for EvaGreen (Bio-Rad) were mixed. Droplets were generated using a QX100 Droplet Generator (Bio-Rad). The following PCR conditions were used: after denaturing at 95 C for 5 min, 40 cycles at 95 C for 30 s and 60 C for 1 min were followed by 1 step at 4 C for 5 min and 90 C for 5 min. Reactions were read in the QX200 Droplet Reader (Bio-Rad).
Chromatin Immunoprecipitation (ChIP) and re-ChIP Chromatin immunoprecipitation was performed essentially as described by Dahl and Collas (2008) . For re-ChIP experiments, the elution for the first immunoprecipitation (RNA polymerase II antibody) was performed in TE-SDS 0.5%, 10 mM DTT for 30 min at 37 C. 10% of the eluted chromatin was then retained as the primary ChIP. The remaining 90% was diluted 20 times in RIPA buffer (Dahl and Collas, 2008) and incubated overnight at 4 C with SMUG1 or IgG (isotype control) antibodies. Immunoprecipitates were then processed as described (Dahl and Collas, 2008) . The purified DNA was analyzed via qPCR. Fold enrichment as percent of input was calculated by normalizing ChIP reactions to input DNA of the target gene.
Telomere ChIP
Telomere ChIP (TeloChIP) analysis was carried out essentially as described previously (Grolimund et al., 2013) . Briefly, cells were washed twice in PBS and cross-linked in 1% formaldehyde-1x PBS for 10 min at room temperature. Glycine (pH 2.5) was added to 125 mM in order to quench the reaction before washing the cells twice with PBS. Cells were lysed in lysis buffer [1% SDS, 10 mM EDTA (pH 8.0), 50 mM Tris-HCl (pH 8.0), EDTA-free protease inhibitor complex] and incubated for 5 min at room temperature, centrifuged for 5 min at 1,500 xg, washed once in lysis buffer and centrifuged as above. The chromatin-enriched pellets were resuspended in lysis buffer and sonicated for 25 cycles with 30 s ON and 30 s OFF per cycle using a Bioruptor (Diagenode). The sonicated lysate was centrifuged at 4 C for 15 min at 20,000 xg. The supernatant was diluted in 2 volumes of ChIP dilution buffer [0.75% Triton gene reverse primers, 2 mL water and 2 mL gDNA (5 ng/mL) to yield a 10-mL reaction. A QuantStudio 7 Flex Real-Time PCR System (Applied Biosystems) was used with reaction conditions of 95 C for 10 min followed by 40 cycles of data collection at 95 C for 15 s, 60 C anneal for 30 s, and 72 C extend for 45 s.
Telomeric DNA Damage Analysis gDNA (200 ng) isolated from mice tissues was digested with 10 U of SMUG1 (New England Biolabs) in a final concentration of 10 mL, at 37 C for 30 min. 5 mL of the reaction were further digested with 10 U of APE1 (New England Biolabs), at 37 C for 30 min. The standard protocol for telomere length analysis via qPCR was then conducted, using 1.5 ng of digested gDNA. Results were normalized to the uncut gDNA qPCR reaction.
TRF Assay
Absolute telomere length analysis was carried out using the TeloTAGGG telomere length assay (Roche) according to the manufacturer's instructions with minor modifications. Briefly, 5 À10 mg of gDNA were digested with RsaI (20 U/reaction) and HinfI (20 U/reaction) restriction enzymes on a final volume of 20 mL, leaving the telomeric and subtelomeric sequence unaffected. In order to evaluate the presence of SMUG1 substrates in telomeric DNA, SMUG1 (5 U/reaction) and APE1 (1 U/reaction) enzymes (New England Biolabs) were added together with RsaI (10 U/reaction) and HinfI (10 U/reaction) on a final volume of 20 mL, using the SmartCut (New England Biolabs) digestion buffer. The digested gDNA was separated using a 0.8% standard gel electrophoresis, transferred via a semi-dry method to a Hybond XL (GE Healthcare) membrane, and hybridized using a DIG-labeled (TTAGGG) 3 oligonucleotide probe. Images were acquired on LAS-3000 mini imaging system (FujiFilm), and quantification was performed using the TeloTool software.
QUANTIFICATION AND STATISTICAL ANALYSIS
All quantified data are presented as mean ± s.e.m., mean ± s.d. and fold change unless stated otherwise (refer to figure legend to detailed information). Student t test or one-way ANOVA were used to assess statistical significance in GraphPad Prism 7 (GraphPad software). A p < 0.05 was considered as statistical significant. P values were indicated with asterisks. Replicates, statistical tests carried out and statistical significances are reported in the corresponding figure legends.
DATA AND CODE AVAILABILITY
Raw and analyzed RNA-seq and 3 0 RACE-seq data have been deposited in the NCBI GEO database under accession number GEO: GSE116580.
